Lydia Hickman is a graduate student in the Cook Lab at the University of Birmingham in the United Kingdom. In her Ph.D. work, she explores the fundamental biological mechanisms underlying motor function and social cognition in the context of autism and Parkinson’s disease. Lydia co-founded the U21 Autism Research Network, an international collaboration among six research groups aiming to improve diversity and inclusion in autism research.
Lydia Hickman
Graduate student
University of Birmingham in the United Kingdom
From this contributor
Ways to make autism research more diverse and inclusive
Scientists must focus on the importance of representative study samples and of engaging with diverse autism community members.
Ways to make autism research more diverse and inclusive
By
Lydia Hickman
14 June 2022 | 6 min read
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
By
Amber Dance
18 September 2026 | 9 min read
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
By
Brendan Borrell
17 September 2026 | 4 min read
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
By
Brady Huggett
17 September 2026 | 2 min read